TEIJIN REGENET

Teijin Regenet is a Japanese contract development and manufacturing organization (CDMO) specializing in the field of regenerative medicine. Established in 2021 as a wholly-owned subsidiary of Teijin Limited, the company provides comprehensive services for the development and production of cell and gene therapy products. It leverages the Teijin Group's expertise in healthcare and materials technology, alongside the manufacturing capabilities of its affiliate, Japan Tissue Engineering Co., Ltd. (J-TEC). Teijin Regenet operates out of facilities in Tokyo and Gamagori, offering support from early-stage process development through to commercial-scale GMP manufacturing. The company aims to accelerate the industrialization of regenerative medicine by providing high-quality, reliable outsourcing solutions to global biotech and pharmaceutical clients.